We evaluated the effects of polymorphic markers within the b globin gene cluster on HbF expression in two groups. These groups were randomly selected from a survey of HbF distribution in a large population study of unrelated healthy Algerian adults (n=827). The first group contained individuals with normal HbF levels (0.1 ± 0.5%) and the second group contained individuals with raised HbF levels (0.8 ± 2.3%). Of the various polymorphic markers analysed, only the 7309 Gg A?G, the 7158 Gg C?T, the Gg IVS2 TC (TG) 9 AG (TG) 2 (CG) 2 and the 7540 b (AT) 9 T 5 sequence configurations were significantly associated with increased HbF levels. More than 84% of the subjects with elevated HbF levels carried one or several of these four marker configurations, suggesting that the b globin gene cluster exerts a significant effect on HbF expression in healthy individuals.
Introduction
The developmental switch from foetal (a 2 g 2 ) to adult (a 2 b 2 ) haemoglobin (Hb) occurs just before birth. In normal subjects: (i) foetal Hb (HbF) constitutes less than 1% of the total Hb by the end of the first year of life; (ii) the synthesis of HbF is restricted to a subpopulation of red cells, known as Fcells (FC), 1, 2 (iii) HbF levels are directly correlated to the number of FC. 3, 4 Hereditary Persistence of Foetal Haemoglobin (HPFH) is characterised by persistently high levels of HbF after birth. Large deletions of varying sizes within the b globin cluster and single base substitutions in the promoter region of one of the two g globin genes result in HPFH, with HbF in the range of 5 ± 30% in heterozygous individuals. 5 These rare forms of HPFH show a clear Mendelian pattern of inheritance and HbF is uniformly distributed among all red blood cells (pancellular HPFH). In the more common form of HPFH, known as Swiss-type HPFH 6 or heterocellular HPFH, HbF levels only increase slightly (1 ± 4%). This form is genetically heterogeneous and seem to result from complex interactions between a variety of genetic determinants, some of which are linked to the b globin gene cluster. Studies have mapped some of the determinants to chromosomes Xp22.2 sickle cell gene, whereas others failed to confirm these findings. 12, 13 Studies of sequence variations in the Locus Control Region hypersensitive site-2 (b LCR 5'HS2), 14 ± 16 the second intron of the A g gene (Ag IVS2), 17 the promoter region of the b globin gene 18, 19 and the -158 5' of the Gg gene 20, 21 have found a genetic association with HbF levels, FC number or both. These association studies have so far been performed exclusively on populations subjected to different degrees of anaemic stress or on carriers of various b globin gene defects. The aim of this study was to determine the effect of these putative genetic markers on HbF expression in healthy adults free from any globin gene defects. We studied seven polymorphic regions of the b globin gene cluster, including four repeat sequences, and evaluated their association with HbF expression in healthy Algerian adults. Our data suggest strongly that there is a significant association between markers of the b globin gene cluster and HbF levels in healthy adults.
Materials and methods
Haematology and haemoglobin analysis Haematological parameters were measured by use of automated counters (STKB Coultronic, Margency, France). HbA 2 and HbF levels were estimated by use of a highly sensitive HPLC method. 22 Population survey for HbF distribution Informed consent was obtained from 859 unrelated Algerian adults. Their age ranged from 18 to 60 years and around 90% of them were younger than 40 years. Thirty-two of the subjects were carriers of S, C or the b thalassemia trait and were excluded from the study. The HbF level was measured in the remaining 827 healthy adults (417 males and 410-non pregnant females).
DNA analysis
Genomic DNA was extracted from the peripheral blood leukocytes of 97 randomly selected subjects: 51 with raised HbF levels and 46 with normal HbF levels. We analysed the entire b globin gene segment and the foetal globin gene promoter region for mutations by use of denaturing gradient gel electrophoresis (DGGE). 23, 24 Deletions in the a globin gene locus were sought by a PCR-based procedure. 25 The following polymorphisms were investigated by use of previously described PCR-based procedures and, when necessary, by sequencing the cloned PCR products. The (AT) x N 12 (AT) y repeat configurations within the 5'HS2 of b LCR, 14 the (TG) n (CG) m configurations in the IVS2 Gg and Ag, 17 the (AT) x T y repeat configuration in the 5' b globin gene, were characterised by size separation and, when appropriate, by direct nucleotide sequencing. 26 The sequence variations, C?G at -369; A?G at -309 and C?T at -158 in the Gg promoter region were explored by PCR-RFLP using BfaI, MboII and XmnI enzymes, respectively.
Statistical analysis
Due to the large size of the study population (males=417; females=410), the Z test 27 was used to compare the mean HbF levels of the two genders. The 262 w test was performed to detect differences in the distribution of repeat sequence configurations and single nucleotide polymorphisms between the phenotype groups. Statistical significance was set at P50.05. Given that some of our genotypes have an unknown gametic phase and include a large number of alleles, Arlequin, a program for the analysis of population genetic data, was used (http://lgb.unige.ch/arlequin) to perform a likelihood method for the analysis of linkage disequilibrium between the pairs of genetic marker configurations in each subgroup and also to establish the maximum likelihood haplotype frequency using an Expectation-Maximization (E.M) algorithm. 28 The relationship between absolute HbF levels and genetic markers was investigated by use of the Students' t-test.
Results

HbF levels in the population
We studied 827 healthy adults (417 males and 410 females) with normal haematologic and Hb profiles. HbF levels ranged between 0.1 and 2.3%. In 520 subjects (62.9%), HbF levels were between 0.2 and 0.3%. In 86 subjects (10.4%) HbF levels were equal or above 0.8%. In 47 of these subjects (54.7%), HbF levels were 51%. The average HbF level in the population was 0.39+0.29% (mean+SD). A significant difference (P50.01; Z test) was noted between males (HbF, 0.35+0.26%) and females (HbF, 0.435+0.312%). A higher proportion of females had increased HbF levels.
Phenotype analysis
We randomly selected 97 subjects for genetic studies: 51 with raised HbF levels (0.8 ± 2.3%; High F group) and 46 with normal range of HbF levels (0.1 ± 0.5%; NRF group). The haematologic indices of these 97 subjects were in the normal range. The means+SD of the High F and NRF subjects were respectively 2.58+0.26% and 2.54+0.25% for HbA2; 14 g/dl+1.12 and 13.42 g/dl+1.43 for total Hb; 41.56%+3.34 and 39.27+4.30% for hematocrit; 85.8 fl+5.06 and 86.15 fl+5.49 for MCV, and 29g/dl+1.88 and 29.98g/dl+2.55 for MCH. These haematologic indices suggest that the b thalassaemic allele is absent in these subjects. This was further confirmed by DNA analysis using a variety of techniques, including nucleotide sequencing when appropriate.
Marker analysis
The DNA regions analysed and the sequence configurations encountered in this study are listed in 
Gg and Ag promoter regions
None of the individuals in the High F group harboured any sequence changes in the Gg and Ag promoter regions (up to 7264 bp), except for the common C?T polymorphism at 7158 of Gg and the 4 bp deletion upstream of Ag (7222 to 7225). The G at 7369 5' of Gg was not polymorphic in either of the groups, whereas the A?G substitution at 7309 was only found in the High F group (n=9). The frequency of the 7158 Gg C?T polymorphism (detected as XmnI-?XmnI+ polymorphism) was statistically different between the two groups (P= 0.02): XmnI+ was present in 51% of High F subjects vs 28% in the NRF group (Figure 2) .
Configurations of the (AT) x N 12 (AT) y motif in b LCR HS2
Ten different sequence configurations of the (AT) x N 12 (AT) y motif were found among the 194 chromosomes studied. The most common configuration in both groups was the A configuration (Table 1a) , which is the reference sequence (GenBank coordinates: 8881-8934). Although the configuration D was much more common in the High F group (52%) than in the NRF group (32.6%) (Table 1b) , the difference was not statistically significant (P=0.06).
Gg IVS2 (TG) n (CG) m configurations
In the Gg IVS2, two novel sequence configurations for (TG) n (CG) m motifs (configurations Q and R) were found in three High F subjects. The prevalence of configurations M and O differed significantly between the two groups: 25.5% of the High F subjects carried configuration M vs 2.27% in the NRF group (P=0.002) and 40.9% of the NRF subjects carried configuration O compared to 5.76% in the High F group (P=0.0001) (Figure 2 ).
5' b globin gene promoter (AT) x (T) y motif
Configuration V (reference sequence) was the most frequent configuration in both two groups (Table 1a) , but the configuration W was significantly more common in the High F group than in the NRF group (P=0.012) (Figure 2 ).
Marker combinations
Over 84% of the High F subjects (43/51) harboured at least one of four sequence configurations, namely G at 7309 of Gg, XmnI+, M and W configurations, compared to only 43% (20/46) of the NRF group (Table 2) . We found that 22 HPFH
High F and 17 NRF subjects carried one of these four sequence configurations. Significantly, more of the subjects in the High F group (37.5 vs 6.5%) contained two configurations. None of the NRF group subjects had three configurations. Table 3 summarises the results of the linkage disequilibrium test between pairs of genetic markers in High F subjects. This test showed linkage disequilibrium (i) between configurations D (b LCR-HS2) and M (Gg IVS2) and between the XmnI+ polymorphism and configurations D, M and W (7540 of b globin gene). However, configuration W was not associated with either D or M. The Arlequin data confirmed that the XmnI+ site is in strict linkage disequilibrium with configuration T in Ag IVS2 as demonstrated earlier, 18 which validates our statistical testing procedure. The maximum likelihood haplotype frequency test failed to reveal any specific associations between the b globin gene cluster haplotypes (constituted by all the studied markers) and the HbF phenotype groups. Genotype/phenotype association Since more than 84% of the High F subjects had at least one of the four sequence configurations compared to 43% of the NRF subjects, we further investigated their combined association with HbF expression for all the studied individuals (Table 4 ). Our data revealed that subjects carrying one, two or three configurations had significantly higher mean absolute HbF values (g/dl) than those not carrying any of these (P50.001). Furthermore, the effect on HbF level was more pronounced when two markers were present than when only one was present (P50.005).
Arlequin tests
Discussion
The amount of HbF in normal adults varied by more than 20-fold. The distribution curve was skewed towards right with around 10% of the subjects having HbF levels above 0.8%. Family studies have shown that a strong genetic component determines the HbF level in subjects at the extremes of this spectrum. 3, 4 This is the reason why we chose subjects at the extreme ends of the spectrum for the further genetic analysis (NRF and High F groups). None of these subjects harboured any b globin gene defects or any anomalies in the foetal globin gene regions. We studied seven polymorphic markers spread through the 40 Kb segment of b globin gene cluster and assessed their association with HbF expression. Four polymorphisms (7309 Gg A?G, 7158 Gg C?T (XmnI+), TC (TG) 9 AG (TG) 2 (CG) 2 in Gg IVS2 and (AT) 9 T 5 5' of the b globin gene) showed a statistically significant independent association with the HbF expression. The 7309 Gg A?G polymorphism was found exclusively in High F subjects. These specific The distribution of four sequence configurations that showed a significant positive association with HbF expression were analysed in High F and NRF subjects. Members of the NRF group were more likely to contain none of the four configurations than were members of the High F group. Conversely, members of High F group were more likely to harbour two or three configurations. The Arlequin test failed to reveal any specific pattern of marker association with HbF expression in High F subjects, suggesting that the contribution of sequence configurations is independent.
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It is interesting that the 7309 Gg A?G variation was only found in the High F group because we (unpublished observations) and others 16, 29 have shown that this variation is specific to the Benin b S haplotype, which is usually associated with low HbF expression. In our study, none of the subjects with 7309 Gg A?G variation had this haplotype and no other population data is available so we can not determine whether, in a context different from the Benin b S haplotype, this polymorphism plays a role in HbF expression. Similarly, the Gg IVS2 TC (TG) 9 AG (TG) 2 (CG) 2 configuration was previously found on two chromosomes associated with the Benin b S haplotype. 29 Our findings show that these two polymorphic markers are also present in normal chromosomes and are associated with raised HbF levels. Conversely, the XmnI+ is a common polymorphism that has been extensively explored in different populations and has been shown to influence the number of FC and HbF levels in normal 30, 31 and anaemic subjects. 20, 21 The (AT) 9 T 5 configuration (configuration W), which is located within a putative transcriptional silencer 32 of the b globin gene, was originally described in a silent b thalassaemia case 33 and has been shown to be associated with reduced sickle gene expression. 34 However, another study involving a few non-anaemic subjects, did not confirm this effect on b globin gene expression. 12 Our data, based on a much larger number of subjects, reveal that this configuration is associated with raised HbF levels. Genes that have minor effects cannot be studied on an individual basis, but their effects may be revealed in a statistical manner through a population study. This might explain why some studies with small number of individuals failed to demonstrate this association.
Of the 22 High F subjects with the (AT) 9 T 5 sequence configuration, 15 had XmnI+. The co-presence of these sequences both in cis and in trans is associated with elevated HbF levels in homozygous and heterozygous b thalassaemia. 18, 19 Our data suggest that even in the absence of any b globin defects, XmnI+ and (AT) 9 T 5 , are strongly associated with elevated levels of HbF. As more than 84% of individuals (43/51) carry at least one of the four marker configurations and as those possessing one of these marker configurations have higher mean HbF levels than those lacking them, these markers may contribute to HbF expression in an independent manner. We cannot totally exclude the possibility that these markers have a direct effect, as they are located in evolutionarily conserved regulatory regions of the globin genes. Alternatively they may act indirectly, as a marker in linkage disequilibrium with an unidentified sequence in the region surrounding this cluster.
This is the first elaborate analysis to have explored the contribution of the b globin gene cluster in the expression of HbF in healthy adults, free of any globin gene defects. We have demonstrated that this cluster makes a significant genetic contribution to HbF. Comparison of the absolute levels of HbF expression in individuals with none of the four markers and in individuals with one or two markers revealed a statistically significant association (*). Similarily, the absolute level of HbF expression was significantly higher in subjects with two markers than in those with one marker (**), suggesting that these markers contribute to HbF expression in an independent manner.
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